British Liver Trust delighted to be supporting major new groundbreaking liver study

January 26, 2026

The largest liver study in the history of the NHS is due for roll out next year, with the aim of preventing thousands of people at risk of liver disease from needing hospital care.

The study is funded by the National Institute for Health and Care Research (NIHR). It will involve over 40,000 people across the UK, half of whom will be invited for screening, via their GPs, for early signs of liver disease.

Co-led by hepatologists from UCL and the University of Leeds, researchers from the University of Nottingham’s School of Medicine have played a major role in designing the study and being awarded funding from NIHR to conduct the research. The collaboration also involves the Universities of Bristol, Dundee, Exeter, and Newcastle, NICE, and the British Liver Trust charity.

Vanessa Hebditch, Director of Communications and Policy at the British Liver Trust said, “We are delighted to be involved in this major new study which will look at how we can best identify people with liver disease in the community and ensure that they get earlier treatment.”

Professor Anthony Gordon, Programme Director for the NIHR Health Technology Assessment (HTA) Programme, which funded the trial, said: “Liver disease claims the lives of thousands of people each year. But evaluating screening interventions through high-quality research studies can hopefully lead to diagnosing this serious condition much earlier and prevent further deterioration.

“Studies like this have the potential to help save lives, improve patient outcomes, and enable people to live healthy, productive lives for longer.”

Preventable liver disease costs the NHS an estimated £4.9 billion annually

The study, the DIAgnosis of Liver diseaSe in primary care (DIALS) trial, has been awarded £3.4million by the NIHR.

Those at higher risk of liver disease due to excessive alcohol intake, Type 2 diabetes or obesity, will be invited for testing by participating GPs and a combination of three non-invasive liver tests will be used to determine the most efficient way to diagnose the condition early.

If these tests show someone might have cirrhosis, they will be referred to a specialist in hospital for further tests and treatment.

More news

Pupils and staff show their true colours to support Harrison

Pupils and staff show their true colours to support Harrison

A Staffordshire primary school has marked the end of term in a very special way, hosting their very own Colour Run to raise funds in support of one of their pupils.   Five-year-old Harrison, who attends Pirehill First School in ...
New cardiovascular framework recognises the vital role of MASLD

New cardiovascular framework recognises the vital role of MASLD

The publication of NHS England's new Cardiovascular Disease Modern Service Framework is an important milestone for people affected by liver disease and a significant step forward in recognising the links between liver, heart, kidney ...
Liver UK launches in Westminster to put liver disease on the political agenda

Liver UK launches in Westminster to put liver disease on the political agenda

Liver UK, the new name for the British Liver Trust and Children’s Liver Disease Foundation, has officially launched in Westminster with a clear message to parliamentarians -- liver disease is rising, largely preventable, and demands ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.